会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • TRIMETHYLAMINE COMPOUNDS AS RISK PREDICTORS OF CARDIOVASCULAR DISEASE
    • 作为心血管疾病风险预防剂的三甲胺化合物
    • US20100285517A1
    • 2010-11-11
    • US12746262
    • 2008-12-05
    • Stanley L. HazenZeneng WangBruce S. Levison
    • Stanley L. HazenZeneng WangBruce S. Levison
    • C12Q1/02G01N33/00
    • G01N33/49G01N33/493G01N33/6893G01N33/92G01N2800/32G01N2800/323G01N2800/50G01N2800/52G01N2800/56H01J49/0036Y10T436/174614
    • Methods of characterizing a test subject's risk of having or developing cardiovascular disease are provided. The methods include using an analytic device to determine levels of choline-related trimethylamine-containing compounds such as trimethylamine N-oxide, choline, or betaine in a biological sample obtained from the subject and comparing the levels of the choline-related trimethylamine-containing compound in the subject's biological sample to a control value. The test subject's risk of having cardiovascular disease is then characterized as higher if the levels of the choline-related trimethylamine-containing compound are higher than the control value. Also provided are methods of identifying a subject at risk of experiencing a complication of atherosclerotic cardiovascular disease, and methods of evaluating the efficacy of a cardiovascular therapeutic agent in a subject with cardiovascular disease using levels of choline-related trimethylamine-containing compounds.
    • 提供测试受试者患有或发展心血管疾病风险的方法。 所述方法包括使用分析装置来确定从受试者获得的生物样品中胆碱相关的含三甲胺的化合物如三甲胺N-氧化物,胆碱或甜菜碱的含量,并比较胆碱相关的含三甲胺的化合物 在受试者的生物样本中达到对照值。 如果胆碱相关的含三甲胺的化合物的含量高于对照值,则测试对象具有心血管疾病的风险的特征就更高。 还提供了鉴定患有动脉粥样硬化性心血管疾病并发症风险的受试者的方法,以及使用胆碱相关的含三甲胺化合物水平的心血管疾病患者评价心血管治疗剂的功效的方法。